Speaking of Chinese business. If I were the China partners and knew NGIO was doing an IPO, understanding they know more about the vaccine potential than we, wouldn't they like to be part of the IPO. Or at least have a Chinese investment bank involved that understands the complexity of China's banking regulations, markets and how their government operates in general regarding USA company partnerships.